Results 211 to 220 of about 161,005 (352)

Troponin T as myocardial ischemia marker to guide therapy with positive inotropes in septic shock patients [PDF]

, 1997
OV Hein, J-P Tessmann, Klaudia Misterek, A. Enders, C. Sanft, W. Schaffartzik, Rudolf Fitzner, Klaus Schröder, CD Spies   +8 more
openalex   +1 more source

The emerging role of Nrf2 in heart failure: From cardioprotection to therapeutic approaches

ESC Heart Failure, EarlyView.
Nrf2 signalling is impaired in heart failure, contributing to oxidative stress, mitochondrial dysfunction, and ferroptosis, which drive neurohormonal activation, inflammation, and ischaemia‐reperfusion injury. This loss of Nrf2 activity exacerbates hypertension, diabetic cardiomyopathy, and cardiotoxicity, accelerating progression to overt heart ...
Emiliano Fiori, Sergio Davinelli, Armando Ferrera, Alessandro Medoro, Carlo Barsali, Allegra Battistoni, Maurizio Volterrani, Massimo Volpe, Luciano Saso, Speranza Rubattu   +9 more
wiley   +1 more source

Prognostic Significance of High-Sensitivity Troponin-T and Hematological Biomarkers in Spontaneous Intracranial Hemorrhage Patients Undergoing Surgery. [PDF]

Diagnostics (Basel)
Öztürk A, Dilbaz S, Çakaroğlu K, Tekin A, Can E, Sönmez E, Ayhan L, Özlük E, Baş NS, Çevik S.   +9 more
europepmc   +1 more source

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

ESC Heart Failure, EarlyView.
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra, Daniela Tomasoni, Marianna Adamo, Offer Amir, Stefan D. Anker, Antoni Bayes‐Genis, Michael Boehm, Javed Butler, Ovidiu Chioncel, Gerasimos Filippatos, Finn Gustafsson, Ewa A. Jankowska, Juan Carlos Kaski, Brenda Moura, Mark C. Petrie, Piotr Ponikowski, Amina Rakisheva, Arsen Ristic, Francois Roubille, Gianluigi Savarese, Petar Seferovic, Peter van der Meer, Maurizio Volterrani, Andrew J. Coats, Vijay K. Chopra, Giuseppe Rosano   +25 more
wiley   +1 more source

Exploring the relationship between intravenous iron therapy and troponin T levels in hemodialysis patients: a cross-sectional study. [PDF]

BMC Nephrol
Hunjul M, Owda D, Sawaid B, Saadeh H, Enaya A, Hamdan Z, Nazzal Z.   +6 more
europepmc   +1 more source

A new staging system for hereditary transthyretin amyloidosis in the era of specific amyloidosis therapies

ESC Heart Failure, EarlyView.
The aim of our study was to develop a more accurate staging system for hereditary ATTR patients currently receiving specific treatment. A staging system was created using as criteria: GLS ≤ −11%, NT‐proBNP ≤ 2,000 ng/L, and eGFR ≤ 65 mL/min. We managed to accurately stratify patients into three disease stages, significantly different in terms of ...
Gabriela Neculae, Amira Zaroui, Robert Adam, Mounira Kharoubi, Benoit Funalot, Daniel Coriu, Ruxandra Jurcut, Thibaud Damy   +7 more
wiley   +1 more source

Surface Modification of Biochar to Prepare Environmentally Friendly Electrochemical Biosensors for Detection of Cardiac Troponin T. [PDF]

ACS Omega
Faria AM, Amoresi RAC, Bach-Toledo L, Andrés J, Mazon T.   +4 more
europepmc   +1 more source

Galectin‐3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE‐TIMI 58

ESC Heart Failure, EarlyView.
Abstract Background Galectin‐3 (Gal‐3) is a circulating biomarker of fibrosis, with higher levels being associated with an increased risk of progression of heart failure and kidney disease. Patients with type 2 diabetes mellitus (T2DM) are at increased risk of both.
Paul M. Haller, Stephen D. Wiviott, David D. Berg, Petr Jarolim, Erica L. Goodrich, Deepak L. Bhatt, Ingrid Gause‐Nilsson, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Itamar Raz, Marc S. Sabatine, David A. Morrow   +12 more
wiley   +1 more source

Plasma troponin T reflects lower motor neuron involvement on electromyography in amyotrophic lateral sclerosis. [PDF]

Brain Commun
Chamoun S, Imrell S, Upate Z, Kläppe U, Öijerstedt L, Yazdani S, Andersson Franko M, Foucher J, Azizi L, Lovik A, Samuelsson K, Press R, Fang F, Svennberg E, Juto A, Ingre C.   +15 more
europepmc   +1 more source

Cardiac troponin-T and diagnostic test evaluation [PDF]

, 1995
Ian Katz, L Wyndham, Les Irwig
openalex   +1 more source